Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETNA: Nesiritide in Acute Decompensated Heart Failure
2004-005213-11Phase 3Terminated
- Sponsor
- GSK
- Start
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Nesiritide + background care with Placebo + background care (2 arms). Primary endpoint: Co-primary endpoints. Started Mar 2005; status: terminated.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2004-005213-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005213-11.